• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Allergy Clin Immunol Pract. Special Article: Risk Communication During COVID-19

tetano

Editor, Senior Moderator
J Allergy Clin Immunol Pract. 2020 Apr 15. pii: S2213-2198(20)30363-9. doi: 10.1016/j.jaip.2020.04.012. [Epub ahead of print]
Special Article: Risk Communication During COVID-19.


Abrams EM[SUP]1[/SUP], Greenhawt M[SUP]2[/SUP].

Author information




Abstract

During the unprecedented times caused by the novel coronavirus COVID-19, there is rapidly evolving information and guidance. However, a focus must also be on proper and effective risk communication. This is especially the case during pandemics that have high rates of infection, significant morbidity, lack of therapeutic measures, and rapid increases in cases, all of which apply to the current COVID-19 pandemic. A consequence of poor risk communication and heightened risk perception is hoarding behavior, which can lead to lack of medications and personal protective equipment. One potential way to ensure appropriate risk communication is utilizing social media channels, and ensuring an ongoing consistent media presence. Another important step is to include all stakeholders including members of the allergy community in broader public health messaging. As we continue to face unprecedented times in the allergy community, an understanding and appreciation of risk communication will be essential as we communicate with, and inform, our patients, and our colleagues, moving forward.
Copyright ? 2020. Published by Elsevier Inc.



KEYWORDS:

COVID-19; SARS-CoV-2; health policy; pandemic planning; risk communication


PMID:32304834DOI:10.1016/j.jaip.2020.04.012
 
Back
Top Bottom